MK
Therapeutic Areas
Shennon Biotechnologies Pipeline
| Drug | Indication | Phase |
|---|---|---|
| T cell Engagers Program | Cancer | Discovery |
| TCR-T Cell Therapy Program | Cancer | Discovery |
Leadership Team at Shennon Biotechnologies
LS
Li Sun, PhD
CEO & Founder
DW
David Weitz, PhD
Scientific Advisor
JF
Joseph Fraietta, PhD
Scientific Advisor